- Home
- UWMC vs RXRX Comparison
UWMC vs RXRX Comparison
Compare UWMC & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | UWMC | RXRX |
|---|---|---|
| Founded | 1986 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.2B |
| IPO Year | 2019 | 2021 |
Fundamental Metrics
Financial Performance| Metric | UWMC | RXRX |
|---|---|---|
| Price | $1.04 | $3.46 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 10 | 7 |
| Target Price | $1.84 | ★ $7.32 |
| AVG Volume (30 Days) | 11.3M | ★ 26.3M |
| Earning Date | 11-05-2026 | 11-04-2026 |
| Dividend Yield | ★ 26.09% | N/A |
| EPS Growth | N/A | ★ 14.79 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $3,160,569,000.00 | $74,681,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $30.44 | $26.91 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 46.07 | 26.92 |
| 52 Week Low | $0.93 | $2.77 |
| 52 Week High | $6.15 | $7.18 |
Technical Indicators
Market Signals| Indicator | UWMC | RXRX |
|---|---|---|
| Relative Strength Index (RSI) | 36.83 | 44.28 |
| Support Level | $0.93 | $2.90 |
| Resistance Level | $1.55 | $3.88 |
| Average True Range (ATR) | 0.09 | 0.44 |
| MACD | -0.00 | -0.08 |
| Stochastic Oscillator | 14.06 | 0.29 |
Price Performance
Historical ComparisonAbout UWMC UWM Holdings Corporation
UWM Holdings Corp engages in the origination, sale, and servicing of residential mortgage loans in the wholesale channel. The company provides independent mortgage advisors across the states and the district of Columbia.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.